These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. [Major drug addiction and dentistry]. Nossintchouk R Bull Acad Natl Chir Dent; 1987; 33(33):91-4. PubMed ID: 3273176 [No Abstract] [Full Text] [Related]
103. The role of the counterphobic mechanism in addiction. SZASZ TS J Am Psychoanal Assoc; 1958 Apr; 6(2):309-25. PubMed ID: 13538877 [No Abstract] [Full Text] [Related]
104. [Psychogenic reasons for drug addiction]. DE NEVES-MANTA IL Imprensa Medica; 1952 Aug; 28(464):25-8. PubMed ID: 13044258 [No Abstract] [Full Text] [Related]
105. Environment and disorders of the circulatory system. BIORCK G Bull N Y Acad Med; 1959 Jan; 35(1):3-24. PubMed ID: 13608175 [No Abstract] [Full Text] [Related]
106. What Is the "Trigger" of Addiction? Asensio S; Hernández-Rabaza V; Orón Semper JV Front Behav Neurosci; 2020; 14():54. PubMed ID: 32372925 [No Abstract] [Full Text] [Related]
107. The individual and the environment. ABBIE AA Med J Aust; 1948 Mar; 1(11):321-7. PubMed ID: 18916356 [No Abstract] [Full Text] [Related]
112. Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice. Marinho EAV; Oliveira-Lima AJ; Reis HS; Santos-Baldaia R; Wuo-Silva R; Hollais AW; Yokoyama TS; Frussa-Filho R; Berro LF Front Pharmacol; 2023; 14():1100527. PubMed ID: 36814501 [No Abstract] [Full Text] [Related]
113. Impact of Mephedrone on Fear Memory in Adolescent Rats: Involvement of Matrix Metalloproteinase-9 (MMP-9) and N-Methyl-D-aspartate (NMDA) Receptor. Grochecki P; Smaga I; Wydra K; Marszalek-Grabska M; Slowik T; Kedzierska E; Listos J; Gibula-Tarlowska E; Filip M; Kotlinska JH Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768263 [TBL] [Abstract][Full Text] [Related]
114. The interaction between Environmental Enrichment and fluoxetine in inhibiting sucrose-seeking renewal in mice depend on social living condition. Pintori N; Piva A; Guardiani V; Marzo CM; Decimo I; Chiamulera C Psychopharmacology (Berl); 2022 Jul; 239(7):2351-2361. PubMed ID: 35353203 [TBL] [Abstract][Full Text] [Related]
115. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder. Petković B; Kesić S; Pešić V Curr Pharm Des; 2020; 26(4):466-484. PubMed ID: 31939725 [TBL] [Abstract][Full Text] [Related]
116. Distinct Populations of Neurons Activated by Heroin and Cocaine in the Striatum as Assessed by catFISH. Vassilev P; Avvisati R; Koya E; Badiani A eNeuro; 2020; 7(1):. PubMed ID: 31937522 [TBL] [Abstract][Full Text] [Related]
117. Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval. Trujillo KA; Heller CY Behav Brain Res; 2020 Jan; 378():112271. PubMed ID: 31593791 [TBL] [Abstract][Full Text] [Related]
118. Opposite environmental gating of the experienced utility ('liking') and decision utility ('wanting') of heroin versus cocaine in animals and humans: implications for computational neuroscience. Badiani A; Caprioli D; De Pirro S Psychopharmacology (Berl); 2019 Aug; 236(8):2451-2471. PubMed ID: 31289884 [TBL] [Abstract][Full Text] [Related]
119. Heroin versus cocaine: opposite choice as a function of context but not of drug history in the rat. De Luca MT; Montanari C; Meringolo M; Contu L; Celentano M; Badiani A Psychopharmacology (Berl); 2019 Feb; 236(2):787-798. PubMed ID: 30443795 [TBL] [Abstract][Full Text] [Related]
120. Non-pharmacological factors that determine drug use and addiction. Ahmed SH; Badiani A; Miczek KA; Müller CP Neurosci Biobehav Rev; 2020 Mar; 110():3-27. PubMed ID: 30179633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]